GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » EV-to-FCF

OWC Pharmaceutical Research (OWC Pharmaceutical Research) EV-to-FCF : 0.00 (As of Jun. 06, 2024)


View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, OWC Pharmaceutical Research's Enterprise Value is $0.00 Mil. OWC Pharmaceutical Research's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2019 was $-2.75 Mil. Therefore, OWC Pharmaceutical Research's EV-to-FCF for today is 0.00.

The historical rank and industry rank for OWC Pharmaceutical Research's EV-to-FCF or its related term are showing as below:

OWCP's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.02
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), OWC Pharmaceutical Research's stock price is $0.0001. OWC Pharmaceutical Research's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.068. Therefore, OWC Pharmaceutical Research's PE Ratio for today is At Loss.


OWC Pharmaceutical Research EV-to-FCF Historical Data

The historical data trend for OWC Pharmaceutical Research's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research EV-to-FCF Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -21.19 -1.71 -46.85 -54.78 -4.57

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OWC Pharmaceutical Research's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, OWC Pharmaceutical Research's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OWC Pharmaceutical Research's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OWC Pharmaceutical Research's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where OWC Pharmaceutical Research's EV-to-FCF falls into.



OWC Pharmaceutical Research EV-to-FCF Calculation

OWC Pharmaceutical Research's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/-2.748
=0.00

OWC Pharmaceutical Research's current Enterprise Value is $0.00 Mil.
OWC Pharmaceutical Research's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OWC Pharmaceutical Research  (OTCPK:OWCP) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

OWC Pharmaceutical Research's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0001/-0.068
=At Loss

OWC Pharmaceutical Research's share price for today is $0.0001.
OWC Pharmaceutical Research's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.068.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


OWC Pharmaceutical Research EV-to-FCF Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Traded in Other Exchanges
N/A
Address
2 Ben Gurion Street, Ramat Gan, ISR, 5257334
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.
Executives
Asher Zwebner director, officer: CHIEF FINANCIAL OFFICER CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Headlines